Vaccinating the world against COVID-19: getting the delivery right is the greatest challenge

Rima Shretta¹, Nathaniel Hupert^{2

3}, Patrick Osewe⁴, Lisa J White^{5

3}

Affiliations

¹ Nuffield Department of Medicine, University of Oxford, Oxford, Oxfordshire, UK rima.shretta@ndm.ox.ac.uk.
² Weill Cornell Medicine and Cornell Institute for Disease and Disaster Preparednes, New York, NY, USA.
³ CoMo Consortium, University of Oxford, Oxford, UK.
⁴ Asian Development Bank, Mandaluyong City, Philippines.
⁵ Nuffield Department of Medicine, University of Oxford, Oxford, Oxfordshire, UK.

Editorial

Rima Shretta et al. BMJ Glob Health. 2021 Mar.

. 2021 Mar;6(3):e005273.

doi: 10.1136/bmjgh-2021-005273.

Rima Shretta¹, Nathaniel Hupert^{2

3}, Patrick Osewe⁴, Lisa J White^{5

3}

¹ Nuffield Department of Medicine, University of Oxford, Oxford, Oxfordshire, UK rima.shretta@ndm.ox.ac.uk.
² Weill Cornell Medicine and Cornell Institute for Disease and Disaster Preparednes, New York, NY, USA.
³ CoMo Consortium, University of Oxford, Oxford, UK.
⁴ Asian Development Bank, Mandaluyong City, Philippines.
⁵ Nuffield Department of Medicine, University of Oxford, Oxford, Oxfordshire, UK.

No abstract available

Keywords: COVID-19; public health; vaccines.

Conflict of interest statement

Competing interests: None declared.

1. Ritchie H, Ortiz-Ospina E, Beltekian D, et al. . Coronavirus (COVID-19) Vaccinations. Our World in Data. Oxford: University of Oxford, 2021. https://ourworldindata.org/covid-vaccinations
1. Zimmer C, Corum J, Wee S-L. Coronavirus Vaccine Tracker New York: New York Times, 2021. Available: https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tra...
1. DHL . Delivery of Covid-19 vaccine: DHL study shows how public and private sector can partner for success. Bonn: DHL, 2020. https://www.dhl.com/global-en/home/press/press-archive/2020/delivery-of-...
1. Gallagher J. Moderna: Covid vaccine shows nearly 95% protection, 2020. https://www.bbc.com/news/health-54902908
1. Pfizer . Pfizer and Biontech announce vaccine candidate against COVID-19 achieved success in first interim analysis from phase 3 study. New York: Pfizer, 2020. https://www.pfizer.com/news/press-release/press-release-detail/pfizer-an...